P012 - Content Variant Corporate Level 3

Facts about ALK 

 

ALK is a global pharmaceutical company focusing on allergy treatment, prevention and diagnosis.

ALK Corporate Headquarters:
Bøge Allé 1
DK-2970 Hørsholm
Denmark
T +45 45 74 75 76
F +45 45 74 86 90


Board of Management:

Jens Bager
President and CEO

Henrik Jacobi
Executive Vice President, Research & Development

Jutta of Rosenborg
CFO & Executive Vice President, Finance & IT

Jørgen Damsbo Andersen
Executive Vice President, Business Operations & International Marketing

Flemming Steen Jensen
Executive Vice President, Product Supply

Number of treated patients

Number of patients treated (in 2007):

 Europe

 450,000

 USA

 750,000

 Other countries

 50,000

 Total

 1,250,000
Facts

Number of employees
(by December 2009):
1,554

Turnover (2009):
DKK 1,935 billion

Result of primary operations
(EBIT, 2009):
DKK 175 million

Research & Development expenses
(2009):
DKK 349 million

Stock exchange listing:
NASDAQ OMX Copenhagen A/S